Resources
Dr. John Lamond Named a 2024 Philadelphia Top Doctor
June 30, 2024 - We’re thrilled to announce that our very own Dr. John Lamond, a leading radiation oncologist, has been recognized as a 2024 Top Doctor by Philadelphia Magazine! This prestigious honor appears in the publication’s May issue and is the result of a rigorous selection process. Philadelphia Magazine partners with Castle Connolly…The Importance of Seeking a Second Opinion After a Cancer Diagnosis
June 20, 2024 - At Philadelphia CyberKnife, we believe that being well-informed about your cancer diagnosis and treatment options is crucial. One of the most effective ways to ensure that you are making the best decisions for your health is by seeking a second opinion. This process can provide you with additional perspectives and…SABR Proven Effective for Early-Stage NSCLC: 2024 Study Highlights
May 20, 2024 - According to research from a phase III randomized international study from The University of Texas MD Anderson Cancer Center, patients with operable stage I non-small cell lung cancer (NSCLC) achieved comparable overall survival rates with stereotactic ablative radiotherapy (SABR), also known as stereotactic body radiation therapy (SBRT), rather than the…Prostate Cancer Treatment and Sexual Function
April 26, 2024 - When deciding which treatment option is best for their prostate cancer, men take numerous factors into consideration. While their physician’s recommendation does play an important role in the treatment decision, in the end, most men make the choice that is best for them. That choice is often based on treatment…Dr. Heuser's Choice
Explore the inspiring story of Dr. Heuser, a distinguished general surgeon, and his critical choice to opt for CyberKnife treatment in his own fight against prostate cancer.
Vernon’s Journey to Relief
Vernon endured the debilitating pain of trigeminal neuralgia for many years. Discover his journey to relief with the CyberKnife and how his life has transformed since having the procedure.
Targeted Cancer Treatment
The CyberKnife system delivers powerful and precise treatment, targeting prostate tumors with high-dose radiation while minimizing damage to surrounding healthy tissue.